Literature DB >> 31468157

CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer.

Yue Wang1, Wei Liu1, Yang Yu2, Jing-Juan Liu1, Hua-Dan Xue1, Ya-Fei Qi1, Jing Lei1, Jian-Chun Yu3, Zheng-Yu Jin4.   

Abstract

PURPOSE: To investigate the role of computed tomography (CT) radiomics for the preoperative prediction of lymph node (LN) metastasis in gastric cancer.
MATERIALS AND METHODS: This retrospective study included 247 consecutive patients (training cohort, 197 patients; test cohort, 50 patients) with surgically proven gastric cancer. Dedicated radiomics prototype software was used to segment lesions on preoperative arterial phase (AP) CT images and extract features. A radiomics model was constructed to predict the LN metastasis by using a random forest (RF) algorithm. Finally, a nomogram was built incorporating the radiomics scores and selected clinical predictors. Receiver operating characteristic (ROC) curves were used to validate the capability of the radiomics model and nomogram on both the training and test cohorts.
RESULTS: The radiomics model showed a favorable discriminatory ability in the training cohort with an area under the curve (AUC) of 0.844 (95% CI, 0.759 to 0.909), which was confirmed in the test cohort with an AUC of 0.837 (95% CI, 0.705 to 0.926). The nomogram consisted of radiomics scores and the CT-reported LN status showed excellent discrimination in the training and test cohorts with AUCs of 0.886 (95% CI, 0.808 to 0.941) and 0.881 (95% CI, 0.759 to 0.956), respectively.
CONCLUSIONS: The CT-based radiomics nomogram holds promise for use as a noninvasive tool in the individual prediction of LN metastasis in gastric cancer. KEY POINTS: • CT radiomics showed a favorable performance for the prediction of LN metastasis in gastric cancer. • Radiomics model outperformed the routine CT in predicting LN metastasis in gastric cancer. • The radiomics nomogram holds potential in the individualized prediction of LN metastasis in gastric cancer.

Entities:  

Keywords:  Gastric cancer; Nomogram; Radiomics

Mesh:

Year:  2019        PMID: 31468157     DOI: 10.1007/s00330-019-06398-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.

Authors:  Wuchao Li; Liwen Zhang; Chong Tian; Hui Song; Mengjie Fang; Chaoen Hu; Yali Zang; Ying Cao; Shiyuan Dai; Fang Wang; Di Dong; Rongpin Wang; Jie Tian
Journal:  Eur Radiol       Date:  2018-12-05       Impact factor: 5.315

2.  Strategies for improving power in diagnostic radiology research.

Authors:  C A Beam
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

3.  An Intelligent Clinical Decision Support System for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.

Authors:  Qiu-Xia Feng; Chang Liu; Liang Qi; Shu-Wen Sun; Yang Song; Guang Yang; Yu-Dong Zhang; Xi-Sheng Liu
Journal:  J Am Coll Radiol       Date:  2019-02-04       Impact factor: 5.532

4.  CT-based radiomics signature for differentiating Borrmann type IV gastric cancer from primary gastric lymphoma.

Authors:  Zelan Ma; Mengjie Fang; Yanqi Huang; Lan He; Xin Chen; Cuishan Liang; Xiaomei Huang; Zixuan Cheng; Di Dong; Changhong Liang; Jiajun Xie; Jie Tian; Zaiyi Liu
Journal:  Eur J Radiol       Date:  2017-04-12       Impact factor: 3.528

Review 5.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Benign regional lymph nodes in gastric cancer on multidetector row CT.

Authors:  Hee Sun Park; Young Jun Kim; Su Yeon Ko; Moon-Won Yoo; Kyung Yung Lee; Sung-Il Jung; Hae Jeong Jeon
Journal:  Acta Radiol       Date:  2012-05-09       Impact factor: 1.990

8.  Radiomic analysis using contrast-enhanced CT: predict treatment response to pulsed low dose rate radiotherapy in gastric carcinoma with abdominal cavity metastasis.

Authors:  Zhen Hou; Yang Yang; Shuangshuang Li; Jing Yan; Wei Ren; Juan Liu; Kangxin Wang; Baorui Liu; Suiren Wan
Journal:  Quant Imaging Med Surg       Date:  2018-05

9.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  28 in total

1.  miRNAs derived from plasma small extracellular vesicles predict organo-tropic metastasis of gastric cancer.

Authors:  Cheng Zhang; Jing Yang; Yang Chen; Jing Gao; Fangli Jiang; Haiyan Liao; Xiang Liu; Yuan Wang; Guanyi Kong; Xiaotian Zhang; Jian Li; Lin Shen
Journal:  Gastric Cancer       Date:  2022-01-15       Impact factor: 7.370

2.  Can PD-L1 expression be predicted by contrast-enhanced CT in patients with gastric adenocarcinoma? a preliminary retrospective study.

Authors:  Xiaolong Gu; Xianbo Yu; Gaofeng Shi; Yang Li; Li Yang
Journal:  Abdom Radiol (NY)       Date:  2022-10-21

Review 3.  Application of radiomics in precision prediction of diagnosis and treatment of gastric cancer.

Authors:  Getao Du; Yun Zeng; Dan Chen; Wenhua Zhan; Yonghua Zhan
Journal:  Jpn J Radiol       Date:  2022-10-19       Impact factor: 2.701

4.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma.

Authors:  Jiahao Gao; Fang Han; Yingying Jin; Xiaoshuang Wang; Jiawen Zhang
Journal:  Front Oncol       Date:  2020-08-27       Impact factor: 6.244

5.  18F-FDG PET-based radiomics model for predicting occult lymph node metastasis in clinical N0 solid lung adenocarcinoma.

Authors:  Lili Wang; Tiancheng Li; Junjie Hong; Mingyue Zhang; Mingli Ouyang; Xiangwu Zheng; Kun Tang
Journal:  Quant Imaging Med Surg       Date:  2021-01

6.  Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.

Authors:  Hongna Tan; Yaping Wu; Fengchang Bao; Jing Zhou; Jianzhong Wan; Jie Tian; Yusong Lin; Meiyun Wang
Journal:  Br J Radiol       Date:  2020-05-27       Impact factor: 3.039

7.  A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer.

Authors:  Yiran Zhang; Yile Lin; Jincai Duan; Ke Xu; Min Mao; Xin Wang
Journal:  Med Sci Monit       Date:  2020-05-15

8.  A CT-based radiomics signature for evaluating tumor infiltrating Treg cells and outcome prediction of gastric cancer.

Authors:  Xujie Gao; Tingting Ma; Shuai Bai; Ying Liu; Yuwei Zhang; Yupeng Wu; Hui Li; Zhaoxiang Ye
Journal:  Ann Transl Med       Date:  2020-04

9.  CT-detected extramural venous invasion is corelated with presence of lymph node metastasis and progression-free survival in gastric cancer.

Authors:  Yu-Tao Yang; San-Yuan Dong; Jue Zhao; Wen-Tao Wang; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Br J Radiol       Date:  2020-10-08       Impact factor: 3.039

10.  Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.

Authors:  Enfa Zhao; Xiaofang Bai
Journal:  Biomed Res Int       Date:  2020-03-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.